By Miho Murata MD, PhD*, Kazuko Hasegawa MD, PhD, Ichiro Kanazawa MD, PhD, Junichi Fukasaka, Kenji Kochi, Rieko Shimazu and The Japan Zonisamide on PD Study Group
Previously, we reported 50 mg/d zonisamide improved wearing-off without increasing dyskinesia in patients with Parkinson’s disease (PD).